信达生物肿瘤创新研发日:新一代“IO+ADC”双重升级,解锁肿瘤治疗新未来

动脉网
Jun 29, 2025

信达生物在肿瘤创新研发日上展示新一代“IO+ADC”双重升级战略,旨在解锁肿瘤治疗新方案,打造国际一流生物制药企业,目标2030年将至少5款创新管线推进至全球多中心III期临床研究。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10